Notice of Award of a Single-Source Cooperative Agreement To Fund Cote d'Ivoire Ministry of Health and Public Hygiene and Universal Health Coverage (MSHPCMU), 9619-9620 [2022-03631]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $1,000,000 for
Year 1 of funding to the Servicos
Provinciais de Sau´de de Inhambane
(SPS Inhambane), Mozambique. The
award will strengthen the institutional
capacity of SPS Inhambane to plan,
coordinate, and supervise HIV-related
activities to contribute to accelerated
progress towards the 95–95–95 goals
(95% of HIV-positive individuals
knowing their status, 95% of those
receiving ART [Antiretroviral therapy],
and 95% of those achieving viral
suppression) and ensure sustainable
control of the epidemic in Mozambique.
Funding amounts for years 2–5 will be
set at continuation.
SUMMARY:
The period for this award will be
September 30, 2022 through September
29, 2027.
DATES:
FOR FURTHER INFORMATION CONTACT:
Meghan Duffy, Center for Global Health,
Centers for Disease Control and
Prevention, U.S. Embassy Maputo,
Avenida Marginal nr 5467,
Sommerschield, Distrito Municipal de
KaMpfumo Caixa Postal 783 CEP 0101–
11 Maputo, Moc
¸ambique, Telephone:
800–232–6348, E-Mail: wwp2@cdc.gov.
The
single-source award will focus on
building institutional capacity of the
SPS in Inhambane for program
development and planning and
strengthening program implementation
and oversight of activities related to HIV
prevention, care, support, and treatment
services funded by PEPFAR in
Mozambique.
SPS Inhambane is in a unique
position to conduct this work, as it is
the sole organization tasked with
ensuring the execution of health
activities at the provincial level in
Inhambane [Decree 26/2020]. In
Mozambique, the governmental public
health infrastructure is organized into
the central or national entity of the
Mozambique Ministry of Health/
Ministe´rio da Sau´de (MOH/MISAU), the
Provincial Health Directorates (DPSs)
that implement activities at the primary
healthcare level, and the Provincial
Health Service (SPS) that lead all health
services within the province of
Inhambane. The SPSs in Mozambique
are government organizations
established by law and mandated to
plan, coordinate, and supervise all
health-related activities at the tertiary
and secondary level, including HIV/
AIDS activities, within their provincial
jurisdiction.
lotter on DSK11XQN23PROD with NOTICES1
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
19:42 Feb 18, 2022
Jkt 256001
Summary of the Award
Recipient: SPS Inhambane,
Mozambique.
Purpose of the Award: The purpose of
this award is to strengthen the
institutional capacity of SPS Inhambane
to plan, coordinate, and supervise HIVrelated activities to contribute to
accelerated progress towards the 95–95–
95 goals and ensure sustainable control
of the epidemic in Mozambique.
Amount of Award: The approximate
year 1 funding amount will be
$1,000,000 in Federal Fiscal Year (FFY)
2022 funds, subject to the availability of
funds. Funding amounts for years 2–5
will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 16, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–03723 Filed 2–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund Cote
d’Ivoire Ministry of Health and Public
Hygiene and Universal Health
Coverage (MSHPCMU)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS) announces the
award of approximately $3,000,000 for
Year 1 of funding to the (MSHPCMU).
The award will strengthen the capacities
of the Ministry of Health (MOH) at the
central and decentralized levels for HIV/
TB infection control interventions.
Funding amounts for years 2–5 will be
set at continuation.
DATES: The period for this award will be
September 30, 2022 through September
29, 2027.
FOR FURTHER INFORMATION CONTACT:
Titania Techeira, Center for Global
Health, Centers for Disease Control and
Prevention, CDC Coˆte d’Ivoire, U.S.
Embassy B.P. 730 Abidjan Cidex 03,
SUMMARY:
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
9619
Telephone: 800–232–6348, E-Mail:
iux2@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will (1) Provide
technical, programmatic, financial, and
administrative support to the ministry
departments for the implementation,
coordination, mobilization, and
supervision of key central-level
prevention, care, and treatment
activities; (2) Link and coordinate
specific activities of various health
ministry departments at the central and
decentralized levels with related
activities by other ministries in the
multi-sectoral HIV/AIDS response; (3)
Develop a sustainability plan which
places an emphasis on national
commitment to health and HIV/AIDS
effort; (4) Plan, monitor, evaluate, and
coordinate expanded service delivery of
prevention of mother to child
transmission (PMTCT), counseling and
testing (CT); and anti-retroviral therapy
(ART) in collaboration with the national
HIV and TB program.
The MOH is the only eligible
applicant that can apply for this funding
opportunity because it is the sole public
sector entity in Cote d’Ivoire mandated
by the government to address the
public’s health needs. This mandate
includes: (1) Coordination, monitoring
and evaluation of comprehensive STI/
TB and HIV prevention, and care and
treatment services; (2) Coordination of
HIV/AIDS interventions at decentralized
levels of the health sector in Cote
d’Ivoire; (3) Lead GoCI institution for
strengthen the regulatory framework
and promote hygiene to prevent
diseases related to poor hospital
hygiene; (4) Lead the GoCI in
strengthening the SI management in the
Ivorian national health sector response
to HIV/AIDS; and Lead the GoCI for the
development of the national M&E plan
to monitor and evaluate the
implementation of the activities and the
results throughout the Ivoirian territory
and at different levels of the health
pyramid.
Summary of the Award
Recipient: MSHPCMU.
Purpose of the Award: The purpose of
this award is to strengthen the
capacities of the MOH at the central and
decentralized levels for HIV/TB
infection control interventions to: (1)
Improve the coordination of HIV/AIDS
control interventions at the
decentralized levels of the health sector;
(2) Strengthen the regulatory framework
and promote hygiene to prevent HIV
infection and healthcare-related
infections; and Strengthen the
management of SI for the health sector
national response.
E:\FR\FM\22FEN1.SGM
22FEN1
9620
Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices
Amount of Award: The approximate
year 1 funding amount will be
$3,000,000 in Federal Fiscal Year (FYY)
2022 funds, subject to the availability of
funds. Funding amounts for years 2–5
will be set at continuation.
Authority: Public Law 108–25 (the
United States Leadership Against HIV
AIDS, Tuberculosis and Malaria Act of
2003).
Period of Performance: September 30,
2022 through September 29, 2027.
Dated: February 15, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2022–03631 Filed 2–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–22–21HD]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled the ‘‘One Health
Surveillance for Zoonotic SARS–CoV–2
Events’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on August
13, 2021 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
VerDate Sep<11>2014
19:42 Feb 18, 2022
Jkt 256001
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
One Health Surveillance for Zoonotic
SARS–CoV–2 Events—New—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
NCEZID seeks OMB approval for One
Health Surveillance for Zoonotic SARS–
CoV–2 Events through the use of two
forms: One Health Case Investigation
Form for Animals with SARS–CoV–2,
and Zoonotic SARS–CoV–2 Event Form.
Description of these forms and activities
associated with this study, including
burden to respondents can be found
below.
Zoonotic SARS–CoV–2 Event Form:
Although it is now well established that
SARS–CoV–2 is a zoonotic virus (i.e.,
can be spread between people and
animals), little information exists on the
prevalence or likelihood of zoonotic
transmission events. Currently,
reporting of zoonotic SARS–CoV–2
transmission events is not
systematically reported. Without this
crucial information, however,
interpreting data on SARS–CoV–2
infection in animals, especially the
overall contribution of zoonotic
transmission to the spread of COVID–
19, is incomplete. The information
gathered using this surveillance
mechanism will provide insight into the
role of animals in SARS–CoV–2
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
transmission and will also provide
context for understanding prevalence of
linked human and animal infections
throughout the nation.
Positive SARS–CoV–2 animal samples
must be confirmed by United States
Department of Agriculture (USDA)
National Veterinary Services Lab
(NVSL); however, without the proposed
surveillance mechanism, data on linked
human and animal transmission events
which yield negative results would not
be tracked at the national level. CDC
and USDA guidance recommends statelevel health authorities, namely state
public health veterinarians and state
animal health officials, are involved in
approving and coordinating animal
SARS–CoV–2 testing. These officials are
therefore the primary target audience for
this surveillance form, in addition to
tribal, local and territorial health
authorities. The Zoonotic SARS–CoV–2
Event form includes questions intended
to improve our understanding of the
number of cases state officials are asked
to consult upon regarding SARS–CoV–
2 testing for potential zoonotic
transmission events, the proportion of
those events that are tested for SARS–
CoV–2, and corresponding relevant
epidemiological data (epidemiological
links to other cases of SARS–CoV–2 in
people or animals, clinical signs, etc.),
results, etc. This form will fill a needed
gap over the next three years.
In addition to the primary reason for
the Zooonotic SARS–CoV–2 Event form,
it will also be used to replace paperbased reporting for CDC-funded
research. Currently, CDC’s One Health
Office has funded surveillance and
research at sites throughout the nation.
This surveillance form will be used to
report all linked human and animal
testing for SARS–CoV–2 to CDC that is
occurring through funded surveillance
activities, including the status and
circumstances for testing. This will
relieve the requirement for less secure
reporting such as paper-based reporting
forms sent through email.
More broadly, we expect this form
may be generalized in the future to
encapsulate surveillance for other
zoonotic respiratory viruses. This
surveillance form therefore offers the
opportunity to test and iterate upon
surveillance mechanisms prior to the
advancement of a broader surveillance
system.
One Health Case Investigation Form
for Animals with SARS–CoV–2:
Currently, most animal samples that test
positive for SARS–CoV–2 are confirmed
by USDA NVSL, and are reported to the
World Organization for Animal Health
(OIE). However, the information
collected is largely restricted to
E:\FR\FM\22FEN1.SGM
22FEN1
]]>Agencies
[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9619-9620]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
Cote d'Ivoire Ministry of Health and Public Hygiene and Universal
Health Coverage (MSHPCMU)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS) announces the
award of approximately $3,000,000 for Year 1 of funding to the
(MSHPCMU). The award will strengthen the capacities of the Ministry of
Health (MOH) at the central and decentralized levels for HIV/TB
infection control interventions. Funding amounts for years 2-5 will be
set at continuation.
DATES: The period for this award will be September 30, 2022 through
September 29, 2027.
FOR FURTHER INFORMATION CONTACT: Titania Techeira, Center for Global
Health, Centers for Disease Control and Prevention, CDC C[ocirc]te
d'Ivoire, U.S. Embassy B.P. 730 Abidjan Cidex 03, Telephone: 800-232-
6348, E-Mail: [email protected].
SUPPLEMENTARY INFORMATION: The single-source award will (1) Provide
technical, programmatic, financial, and administrative support to the
ministry departments for the implementation, coordination,
mobilization, and supervision of key central-level prevention, care,
and treatment activities; (2) Link and coordinate specific activities
of various health ministry departments at the central and decentralized
levels with related activities by other ministries in the multi-
sectoral HIV/AIDS response; (3) Develop a sustainability plan which
places an emphasis on national commitment to health and HIV/AIDS
effort; (4) Plan, monitor, evaluate, and coordinate expanded service
delivery of prevention of mother to child transmission (PMTCT),
counseling and testing (CT); and anti-retroviral therapy (ART) in
collaboration with the national HIV and TB program.
The MOH is the only eligible applicant that can apply for this
funding opportunity because it is the sole public sector entity in Cote
d'Ivoire mandated by the government to address the public's health
needs. This mandate includes: (1) Coordination, monitoring and
evaluation of comprehensive STI/TB and HIV prevention, and care and
treatment services; (2) Coordination of HIV/AIDS interventions at
decentralized levels of the health sector in Cote d'Ivoire; (3) Lead
GoCI institution for strengthen the regulatory framework and promote
hygiene to prevent diseases related to poor hospital hygiene; (4) Lead
the GoCI in strengthening the SI management in the Ivorian national
health sector response to HIV/AIDS; and Lead the GoCI for the
development of the national M&E plan to monitor and evaluate the
implementation of the activities and the results throughout the
Ivoirian territory and at different levels of the health pyramid.
Summary of the Award
Recipient: MSHPCMU.
Purpose of the Award: The purpose of this award is to strengthen
the capacities of the MOH at the central and decentralized levels for
HIV/TB infection control interventions to: (1) Improve the coordination
of HIV/AIDS control interventions at the decentralized levels of the
health sector; (2) Strengthen the regulatory framework and promote
hygiene to prevent HIV infection and healthcare-related infections; and
Strengthen the management of SI for the health sector national
response.
[[Page 9620]]
Amount of Award: The approximate year 1 funding amount will be
$3,000,000 in Federal Fiscal Year (FYY) 2022 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: Public Law 108-25 (the United States Leadership Against
HIV AIDS, Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30, 2022 through September 29,
2027.
Dated: February 15, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2022-03631 Filed 2-18-22; 8:45 am]
BILLING CODE 4163-18-P
